Telangana unveils next generation life sciences policy 2026-2030 at Davos; sees $25 billion investment, 5 lakh jobs

The Telangana government at the ongoing annual meeting of the World Economic Forum (WEF) in Davos unveiled the new Next-Gen Life Sciences Policy 2026-2030, which is expected to serve as a guiding framework as the state looks to leapfrog from a scale-driven manufacturing approach to value-driven, innovation-driven growth.

Purpose of the policy

The ambition is to position Telangana as a globally integrated Life Sciences hub for discovery, development and deployment and to be among the top five life sciences clusters globally by 2030. The policy aims at $25 billion in investments, creation of five lakh high-quality jobs and deeper integration into global life sciences value chains, Industries and IT Minister D. Sridhar Babu said after Chief Minister A. Revanth Reddy and others launched the policy.

Emphasis on cross-border cooperation

“We are building one of the world’s most trusted and transformational life sciences ecosystems, driving Telangana’s global health impact. The global policy unveiling at Davos reflects Telangana’s belief that the next phase of growth in life sciences will be driven by cross-border collaboration, global capital and shared innovation agendas,” said Mr. Revanth Reddy.

The state government is keen for Telangana to play a much bigger role in shaping the future of global healthcare, advanced therapies and sustainable biomanufacturing. The Next-Gen Life Sciences Policy represents a deliberate scale-up designed to accelerate Telangana’s transition from being indispensable to global supply chains to a global originator of advanced therapies and platforms, the Minister’s Office said.

Groundbreaking science and advanced manufacturing platforms are prioritized

“In the last two years alone, we have been able to attract investments of ₹73,000 crore. With the launch of new policies, we are now aiming higher to attract ₹2 Lakh crore in the next five years. The policy prioritises cutting-edge science and advanced manufacturing platforms, including cell and gene therapies, peptides, precision fermentation and other next-generation modalities,” said Mr. Sridhar Babu.

The policy will strengthen the broader ecosystem of clinical research, pharmaceutical services, diagnostics, medical electronics and digital health – making Telangana a destination of choice for global life sciences hubs, he said. Special Chief Secretary Sanjay Kumar and Telangana Lifesciences CEO Shakthi M. Nagappan were present.

“The policy is not just a framework. It is designed to accelerate the adoption of breakthrough technologies such as AI, digital health and next-generation therapies, while nurturing skilled talent. A key reform is the recognition of R&D units as full-fledged industrial enterprises, giving them equal access to incentives and strengthening the state’s commitment to innovation and high-quality scientific activities,” said Mr. Sanjay Kumar.

Life Sciences Innovation Fund of $100 million

Mr. Nagappan said the new policy will strengthen Telangana’s integration into the global life sciences value chain. A dedicated Life Sciences Innovation Fund, scalable up to ₹1,000 crore ($100 million) will catalyze early and growth-stage innovation and support deep-tech ventures, particularly in biotherapeutics. Another key initiative proposed is the establishment of the Telangana School of Life Sciences, a university of global excellence focused on research, education and future-proof talent development.

The policy implementation will be anchored by a globally benchmarked infrastructure, including the Green Pharma City, ten Pharma Villages, expansion of Genome Valley and further strengthening of the Medical Devices Park.